Trastuzumab-associated cardiac events in the Persephone trial

BACKGROUND: We report cardiac events in the Persephone trial which compares 6–12 months of adjuvant trastuzumab in women with confirmed HER2-positive, early-stage breast cancer. METHODS: Clinical cardiac events were defined as any of the following: symptoms and/or signs of congestive heart failure (...

Descripción completa

Detalles Bibliográficos
Autores principales: Earl, Helena M, Vallier, Anne-Laure, Dunn, Janet, Loi, Shrushma, Ogburn, Emma, McAdam, Karen, Hughes-Davies, Luke, Harnett, Adrian, Abraham, Jean, Wardley, Andrew, Cameron, David A, Miles, David, Gounaris, Ioannis, Plummer, Chris, Hiller, Louise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5155357/
https://www.ncbi.nlm.nih.gov/pubmed/27875516
http://dx.doi.org/10.1038/bjc.2016.357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5155357/
https://www.ncbi.nlm.nih.gov/pubmed/27875516
http://dx.doi.org/10.1038/bjc.2016.357

Ejemplares similares